Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome

Early trials have shown a massive reduction in seizures among young people with Dravet syndrome

Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome

Il farmaco sperimentale zorevunersen ha mostrato una riduzione delle crisi motorie dell'85% nei bambini affetti dalla rara patologia